Logo image of USGO

US GOLDMINING INC (USGO) Stock Fundamental Analysis

NASDAQ:USGO - Nasdaq - US90291W1080 - Common Stock - Currency: USD

9.635  -0.03 (-0.26%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to USGO. USGO was compared to 153 industry peers in the Metals & Mining industry. While USGO has a great health rating, there are worries on its profitability. USGO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year USGO has reported negative net income.
USGO had a negative operating cash flow in the past year.
USGO had negative earnings in each of the past 5 years.
In the past 5 years USGO always reported negative operating cash flow.
USGO Yearly Net Income VS EBIT VS OCF VS FCFUSGO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -2M -4M -6M -8M

1.2 Ratios

The Return On Assets of USGO (-164.83%) is worse than 96.08% of its industry peers.
The Return On Equity of USGO (-190.93%) is worse than 90.85% of its industry peers.
Industry RankSector Rank
ROA -164.83%
ROE -190.93%
ROIC N/A
ROA(3y)-307.97%
ROA(5y)-232.47%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
USGO Yearly ROA, ROE, ROICUSGO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500 -500

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for USGO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
USGO Yearly Profit, Operating, Gross MarginsUSGO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024

More info and screens

8

2. Health

2.1 Basic Checks

Compared to 1 year ago, USGO has more shares outstanding
USGO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
USGO Yearly Shares OutstandingUSGO Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
USGO Yearly Total Debt VS Total AssetsUSGO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

USGO has an Altman-Z score of 91.58. This indicates that USGO is financially healthy and has little risk of bankruptcy at the moment.
USGO's Altman-Z score of 91.58 is amongst the best of the industry. USGO outperforms 97.39% of its industry peers.
There is no outstanding debt for USGO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 91.58
ROIC/WACCN/A
WACCN/A
USGO Yearly LT Debt VS Equity VS FCFUSGO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 9.80 indicates that USGO has no problem at all paying its short term obligations.
With an excellent Current ratio value of 9.80, USGO belongs to the best of the industry, outperforming 90.20% of the companies in the same industry.
A Quick Ratio of 9.72 indicates that USGO has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 9.72, USGO belongs to the top of the industry, outperforming 90.20% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 9.8
Quick Ratio 9.72
USGO Yearly Current Assets VS Current LiabilitesUSGO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for USGO have decreased strongly by -44.16% in the last year.
EPS 1Y (TTM)-44.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-623.94%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y15.94%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
USGO Yearly EPS VS EstimatesUSGO Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 -0.2 -0.4 -0.6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for USGO. In the last year negative earnings were reported.
Also next year USGO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
USGO Price Earnings VS Forward Price EarningsUSGO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
USGO Per share dataUSGO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

USGO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

US GOLDMINING INC

NASDAQ:USGO (5/28/2025, 8:05:58 PM)

9.635

-0.03 (-0.26%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-19 2025-02-19
Earnings (Next)N/A N/A
Inst Owners5.02%
Inst Owner Change52.52%
Ins Owners4.28%
Ins Owner Change0.03%
Market Cap120.53M
Analysts82.86
Price Target27.03 (180.54%)
Short Float %3.38%
Short Ratio1.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 27.12
P/tB 27.12
EV/EBITDA N/A
EPS(TTM)-0.68
EYN/A
EPS(NY)-0.59
Fwd EYN/A
FCF(TTM)-0.63
FCFYN/A
OCF(TTM)-0.62
OCFYN/A
SpS0
BVpS0.36
TBVpS0.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -164.83%
ROE -190.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-307.97%
ROA(5y)-232.47%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 136.78%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.8
Quick Ratio 9.72
Altman-Z 91.58
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-44.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-623.94%
EPS Next Y15.94%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-44.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year61.58%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-3906.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3819.41%
OCF growth 3YN/A
OCF growth 5YN/A